Recordati Industria Chimica e Farmaceutica S.p.A. (BIT: REC)
Italy
· Delayed Price · Currency is EUR | Market Cap | 10.66B |
| Revenue (ttm) | 2.22B |
| Net Income (ttm) | 387.01M |
| Shares Out | 204.87M |
| EPS (ttm) | 1.85 |
| PE Ratio | 28.12 |
| Forward PE | 22.54 |
| Dividend | 1.20 (2.27%) |
| Ex-Dividend Date | May 20, 2024 |
| Volume | 188,001 |
| Open | 52.25 |
| Previous Close | 52.80 |
| Day's Range | 52.00 - 52.55 |
| 52-Week Range | 43.04 - 53.40 |
| Beta | 0.40 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 8, 2024 |
About REC
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing’s syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. T... [Read more]
Financial Performance
In 2023, LDO's revenue was 15.29 billion, an increase of 3.93% compared to the previous year's 14.71 billion. Earnings were 658.00 million, a decrease of -29.02%.
Financial StatementsNews
5 High-Quality Stocks in the Mediterranean
According to the High Quality Screener, a Premium All-in-One Screener template, five high-quality stocks based in Mediterranean countries are Diasorin SpA (MIL:DIA), Koza Altin Izletmeleri AS (IST:KOZ...